Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction

Life Sciences

Volumn 89, Issue 5-6, 2011, Pages 195-203

  Tsutsumi, Toshihiko ^a   Adachi, Mika ^b   Nikawadori, Miki ^b   Morishige, Junichi ^a,c   Tokumura, Akira ^b  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Lysophosphatidylcholine; Lysophospholipase D; Lysophospholipid; Renal fibrosis

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; CREATININE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; ENZYME ACTIVITY; HYDRONEPHROSIS; KIDNEY CELL; KIDNEY CIRCULATION; KIDNEY TUBULE; MALE; MOLECULE; NONHUMAN; PELVIS; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; URINARY EXCRETION;

RATTUS;

EID: 80051791207     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.06.001     Document Type: Article

References (36)

1. Akin M, Demirbilek S, Ay S, Gurunluoglu K, Turkmen E, Tas E, et al. Attenuation of ureteral obstruction-induced renal injury by polyenylphosphatidylcholine. Int J Urol 2007;14:350-6. (Pubitemid 46669049)
2. +-adenosine triphosphatase activity in cultured hamster renal tubular cells. Toxicol Appl Pharmacol 1994;125: 176-83. (Pubitemid 24142291)
3. Bascands JL, Schanstra JP. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005;68:925-37. (Pubitemid 43246409)
4. Bektas M, Payne SG, Liu H, Goparaju S, Milstien S, Spiegel S. A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J Cell Biol 2005;169:801-11. (Pubitemid 41002885)
5. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
6. 2+ and contractility in cultured rat mesangial cells. Circ Res 1995a;77: 888-96.
7. Inoue CN, Ko YH, Guggino WB, Forster HG, Epstein M. Lysophosphatidic acid and platelet-derived growth factor synergistically stimulate growth of cultured rat mesangial cells. Proc Soc Exp Biol Med 1995b;216:370-9.
8. Ishii S, Noguchi K, Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 2009;89:57-65.
9. Kamanna VS, Bassa BV, Ganji SH, Roh DD. Bioactive lysophospholipids and mesangial cell intracellular signal pathway: role in the pathobiology of kidney disease. Histol Histopathol 2005;20:603-13. (Pubitemid 40468279)
10. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-75. (Pubitemid 35192452)
11. Kohjimoto Y, Honeyman TW, Jonassen J, Gravel K, Kennington L, Scheid CR. Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kidney Int 2000;58:638-46. (Pubitemid 30620013)
12. Kumagai N, Inoue CN, Kondo Y, Iinuma K. Mitogenic action of lysophosphatidic acid in proximal tubular epithelial cells obtained from voided human urine. Clin Sci 2000;99: 561-7. (Pubitemid 32014564)
13. Masaki T, Fori R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 2003;63:1256-64. (Pubitemid 36349991)
14. Noguchi K, Herr D, Mutoh T, Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opinion Pharmacol 2009;9:15-23.
15. Ohkawa R, Hisano N, Nakamura K, Okubo S, Yokota H, Yatomi Y. Lysophosphatidic acid activity exists in the urine to catalyse the formation of lysophosphatidic acid. Nephrol Dial Transplant 2006;21:3612-3 (Pubitemid 44817136)
16. Philippson C. The phosphatidylcholine metabolism inthe renal tissue during experimental acute and chronic pyelonephritis in the rabbit. Exp Pathol 1986;30:165-71.
17. 1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol 2007;18:3110-8. (Pubitemid 350223970)
18. Pradère JP, Gonzalez J, Klei J, Valet P, Grès S, Salant D, et al. Lysophosphatidic acid and renal fibrosis. Biochim Biophy Acta 2008;1781:582-7.
19. Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. J Nutr Vitaminol 1998;44:809-18. (Pubitemid 29091148)
20. Schanstra JP, Neau E, Drogoz P, Arevalo Gomez MA, Lopez Novoa JM, Calise D, et al. In vivo bradykinin B receptor activation reduces renal fibrosis. J Clin Invest 2002;110:371-9. (Pubitemid 34847969)
21. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999;96:6931-6. (Pubitemid 29274987)
22. Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 1994;267:C204-10.
23. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog Lipid Res 1995;34:151-84.
24. Tokumura A, Fujimoto H, Yoshimoto O, Nishioka Y, Miyake M, Fukuzawa K. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats. Life Sci 1999;65:245-53. (Pubitemid 29320406)
25. Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim Biophys Acta 2002;1582:18-25. (Pubitemid 34634107)
26. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002;277:39436-42. (Pubitemid 35190918)
27. Tokumura A. Metabolic pathways and physiological and pathophysiological significances of lysolipidphosphate mediators. J Cell Biochem 2004;92:869-81. (Pubitemid 44264238)
28. Tokumura A, Kume T, Fukuzawa K, Tahara M, Tasaka K, Aoki J, et al. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. Life Sci 2007;80:1641-9. (Pubitemid 46441268)
29. Tokumura A, Carbon LD, Yoshioka Y, Morishige J, Kikuchi M, Postlethwaite A, et al. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. Int J Med Sci 2009;6:168-76.
30. Troyer DA, Kreisberg JI, Venkatachalam MA. Lipid alterations in LLC-PK1 cells exposed to mercuric chloride. Kidney Int 1986;29:530-8. (Pubitemid 16129064)
31. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002;158:227-33.
32. 2 as an autocrine growth factor mediating interleukin-1 action on mesangial cells. Biochim Biophys Acta 1997;1345:99-108. (Pubitemid 27105907)
33. Xing Y, Ganji SH, Noh JW, Kamanna VS. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth. Am J Physiol Renal Physiol 2004;287:F1250-7. (Pubitemid 39507234)
34. Xu Y, Fang XJ, Casey G, Mills GB. Lysophospholipids activate ovarian and breast cancer cells. Biochem J 1995;309:933-40.
35. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ. Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 2001;16: 1769-75. (Pubitemid 32821407)
36. Zhao X, Wang D, Zhao Z, Xiao Y, Sengupta S, Xiao Y, et al. Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells. J Biol Chem 2006;281:29357-68. (Pubitemid 44507079)